4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-20-014226
EVP, Chief Commercial Officer acquired 6,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Cumbo Alexander · EVP, Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-28 | Grant or award : show line 1 in the form | +6,700 | 8,567 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-02-28 | Grant or award : show line 2 in the form Stock option (right to buy) | +37,500 | $114.47 | 2030-02-28 | 37,500 | 37,500 | D |
Loading xslF345X03/doc4.xml…